Pharma
As drug–device combination products continue demonstrate growth at a rapid pace, the experts in drug delivery alongside device development engineers at the #VLDDCP summit will offer diverse perspectives on ensuring the compatibility and operational efficiency of drug products and delivery devices, exploring recent experience in the digital health, connected combination products and wearable injectors.
The 6th Drug-Device Combination Products Conference in Berlin aims to address the critical importance of ensuring harmony between drug products and their delivery mechanisms, particularly during the challenging initial phases of development when finalising formulations and dosage while navigating regulatory complexities presents significant hurdles to the successful advancement of sustainable and connected combined drug-device products.
Read moreAs drug–device combination products continue demonstrate growth at a rapid pace, the experts in drug delivery alongside device development engineers at the #VLDDCP summit will offer diverse perspectives on ensuring the compatibility and operational efficiency of drug products and delivery devices, exploring recent experience in the digital health, connected combination products and wearable injectors.
The combination products professionals will focus on:
The 6th Drug-Device Combination Products Conference in Berlin aims to address the critical importance of ensuring harmony between drug products and their delivery mechanisms, particularly during the challenging initial phases of development when finalising formulations and dosage while navigating regulatory complexities presents significant hurdles to the successful advancement of sustainable and connected combined drug-device products.
Chief Executives, Vice Presidents, Directors, Heads, Leaders, and Managers specialising in:
The Early Bird Offer expires in 47 days!
To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.
The Early Bird Offer expires in 47 days!
About Speaker
Teva Pharmaceuticals
About Speaker
Emergo by UL
About Speaker
Sandoz Device Development Centre
About Speaker
Clexio Biosciences
About Speaker
Paul Johnson Consulting Limited
About Speaker
About Speaker
Bjarne Sørensen is a director of front-end innovation at Phillips-Medisize, based in the company’s development centre in Denmark. With more than 35 years of experience within product, strategy, and business development, Bjarne has a very visible track record within different business areas. At Phillips-Medisize, he participates in customer projects, typically involving electronic injectors and connected health systems. He is also deeply involved in new electronic platform programs, especially on conceptual, technical, and sustainability aspects.
Teva Pharmaceuticals
Emergo by UL
Yvonne Limpens is a managing human factors specialist with Emergo by UL’s Human Factors Research & Design (HFR&D) team based in Utrecht, The Netherlands. She has been with the team since 2013 and has experience delivering HFE services to the medical device and pharmaceutical industries. Yvonne leads and oversees research activities and helps clients develop key HFE documents for their design history files. Furthermore, she advises and trains clients on how to apply HFE during product development to meet regulators' expectations. Yvonne holds a BSc in industrial design and an MSc in human technology interaction, both from Eindhoven University of Technology (NL).
Sandoz Device Development Centre
Clexio Biosciences
Paul Johnson Consulting Limited
Paul Johnson is an independent consultant to the pharmaceutical industry who has specialised in the CMC aspects of NCE and generic inhaled product development since 2018 serving clients in large/small pharma companies, pharmaceutical component suppliers, and pharmaceutical service providers.
Paul gained 20 years of experience leading teams and projects involved for the development of inhaled products at Glaxo Smith Kline in a range of delivery systems, including dry powder inhalers, pressurised metered dose inhalers, and nebulisers. He is most proud to have led the CMC teams from early development, through clinical stages, registration, launch and lifecycle management for Relvar/Breo Ellipta, and provided leadership for the CMC aspects for the entire GSK inhaled franchise.
Ph.D. in Strategy and Organizations, Juan has specialized in regulatory compliance projects for devices and combination products, particularly focusing on the new Medical Device Regulation. Juan both leads and acts as subject matter expert in the MDR-remediation for pharmaceutical clients and the submissions for Notified Body Opinions for drug-device combinations.
Teva Pharmaceuticals
Emergo by UL
Sandoz Device Development Centre
Clexio Biosciences
Paul Johnson Consulting Limited
Request the 6th Drug-Device Combination Products Conference brochure and find out the latest topics and ideas that will be shared.
Please fill in your e-mail address below and we will process your request in a moment.
Mar 1, 2023
9th Pre-Filled Syringes, Injection Devices & Parenteral Systems Summit
Pharma
Pharma
Pharma
Pharma
